Skip to main content
. 2007 Dec 4;98(1):71–76. doi: 10.1038/sj.bjc.6604121

Table 2. Activity of the treatment.

Parameter n (%)
Partial response 15/43 (34.9%)
Stable disease 12/43 (27.9%)
Progressive disease 12/43 (27.9%)
   
Median response duration 5.3 months (range: 0.9–20.9)
Median PFS 7.8 months (95% CI: 6.7–10)
Median OS 13.9 months (95% CI: 11.2–19.9)

CI=confidence interval; OS=overall survival; PFS=progression-free survival.